Inventor · disambiguated record
Jiping Fu
Also filed as: FU JIPING
35 granted patents·21 pending applications·139 citations·filing 2007–2025
96Inventor score
Top patents by PatentIndex Score
56 records- 0197US11267782B2Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitorsNIKANG THERAPEUTICS INC·Filed 2021·Granted Mar 8, 2022·6 cites·26 claims
- 0297US11034705B2Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitorsNIKANG THERAPUETICS INC·Filed 2020·Granted Jun 15, 2021·29 cites·58 claims
- 0396US11753366B2Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitorsNIKANG THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·3 cites·6 claims
- 0496US11420936B2Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseasesNIKANG THERAPEUTICS INC·Filed 2022·Granted Aug 23, 2022·2 cites·15 claims
- 0594US10894797B2Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitorsNIKANG THERAPUETICS INC·Filed 2020·Granted Jan 19, 2021·3 cites·30 claims
- 0694US9845325B2Tetracyclic pyridone compounds as antiviralsNOVARTIS AG·Filed 2017·Granted Dec 19, 2017·24 cites·15 claims
- 0793US11634382B2Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrileNIKANG THERAPEUTICS INC·Filed 2021·Granted Apr 25, 2023·2 cites·37 claims
- 0893US10301312B2Fused indazole pyridone compounds as antiviralsNOVARTIS AG·Filed 2018·Granted May 28, 2019·7 cites·18 claims
- 0989US9549916B2Isoxazole hydroxamic acid compounds as LpxC inhibitorsFU JIPING·Filed 2015·Granted Jan 24, 2017·10 cites·20 claims
- 1088US8008263B2Organic compounds and their usesNOVARTIS AG·Filed 2008·Granted Aug 30, 2011·12 cites·17 claims
- 1187US11518772B2Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitorsNIKANG THERAPEUTICS INC·Filed 2020·Granted Dec 6, 2022·1 cites·10 claims
- 1287US2025340508A1Tetrahydro-1h-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitorsNIKANG THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1385US12391642B2Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitorsNIKANG THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·19 claims
- 1485US8222425B2Organic compounds and their usesBRITT SHAWN D·Filed 2011·Granted Jul 17, 2012·12 cites·5 claims
- 1585US7825152B2Organic compounds and their usesNOVARTIS AG·Filed 2007·Granted Nov 2, 2010·7 cites·30 claims
- 1683US11459340B2Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitorsNIKANG THERAPEUTICS INC·Filed 2019·Granted Oct 4, 2022·1 cites·8 claims
- 1783US10093673B2Tetracyclic pyridone compounds as antiviralsNOVARTIS AG·Filed 2017·Granted Oct 9, 2018·3 cites·16 claims
- 1881US12264167B2Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitorsNIKANG THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·11 claims
- 1981US2025361203A1Processes of making 3-fluoro-5-(((1s,2ar)-1,3,3,4,4 pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1h-cyclopenta[cd]inden-7-yl)oxy)benzonitrile and polymorphs thereofNIKANG THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2079US9718792B2Isoxazoline hydroxamic acid derivatives as LpxC inhibitorsNOVARTIS AG·Filed 2017·Granted Aug 1, 2017·1 cites·16 claims
- 2179US8211932B2Organic compounds and their usesPATANE MICHAEL·Filed 2010·Granted Jul 3, 2012·5 cites·15 claims
- 2278US12435034B2Process of preparing 3-fluoro-5(((1R,2AR)-3,3,4,4-tetrafluoro-1,2A-dihydroxy-2,2A,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrileNIKANG THERAPEUTICS INC·Filed 2023·Granted Oct 7, 2025·0 cites·20 claims
- 2378US11234977B2Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antiviralsNOVARTIS AG·Filed 2018·Granted Feb 1, 2022·1 cites·20 claims
- 2478US8445527B2Organic compounds and their usesPATANE MICHAEL·Filed 2012·Granted May 21, 2013·4 cites·9 claims
- 2577US12415779B2Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereofNIKANG THERAPEUTICS INC·Filed 2022·Granted Sep 16, 2025·0 cites·34 claims
- 2676US8324239B2Furopyridine compounds and uses thereofBARNES DAVID·Filed 2011·Granted Dec 4, 2012·4 cites·10 claims
- 2776US2021347729A1Tetrahydro-1h-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitorsNIKANG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2874US9815804B2Isoxazole hydroxamic acid compounds as LpxC inhibitorsNOVARTIS AG·Filed 2016·Granted Nov 14, 2017·1 cites·19 claims
- 2974US2022380302A1Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseasesNIKANG THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3070US2020361855A1Tetrahydro-1h-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitorsNIKANG THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3168US10975078B2Fused indazole pyridone compounds as antiviralsNOVARTIS AG·Filed 2020·Granted Apr 13, 2021·0 cites·5 claims
- 3268US9637482B2Isoxazoline hydroxamic acid derivatives as LpxC inhibitorsFU JIPING·Filed 2015·Granted May 2, 2017·1 cites·17 claims
- 3367US2019300530A1Fused indazole pyridone compounds as antiviralsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3466US2022105091A1Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antiviralsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 3565US2024287100A1Alkylidene derivatives as kras inhibitorsNIKANG THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3660US10029994B2Isoxazole hydroxamic acid compounds as LpxC inhibitorsNOVARTIS AG·Filed 2017·Granted Jul 24, 2018·0 cites·8 claims
- 3759US2024166669A1Quinazoline amine derivatives as kras inhibitorsNIKANG THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3859US2025018049A1Compounds for degrading cyclin-dependent kinase 2 via ubiquitin proteosome pathwayNIKANG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3957US2013149281A1Organic compounds and their usesNOVARTIS AG·Filed 2013·Application pending·0 cites
- 4054US2022274914A1Tricyclic derivatives as hypoxia inducible factor-2(alpha) inhibitorsNIKANG THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4152US12077506B2Indane derivatives as hypoxia inducible factor-2(α) inhibitorsNIKANG THERAPEUTICS INC·Filed 2019·Granted Sep 3, 2024·0 cites·23 claims
- 4251US12171741B22,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitorsNIKANG THERAPEUTICS INC·Filed 2019·Granted Dec 24, 2024·0 cites·23 claims
- 4351US2022177487A1Fused polycyclic pyridone compounds as influenza virus replication inhibitorsNIKANG THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4451US2009197856A1Antiviral compoundsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 4549US9072696B2Cyclic peptides and use as medicinesFU JIPING·Filed 2013·Granted Jul 7, 2015·0 cites·22 claims
- 4648US10071973B2Crystalline isoxazole hydroxamic acid compoundsNOVARTIS AG·Filed 2017·Granted Sep 11, 2018·0 cites·15 claims
- 4747US2008045530A1Organic Compounds and Their UsesBRANDL TRIXI·Filed 2007·Application pending·0 cites
- 4846US2021355104A1Adenosine receptor binding compoundsNIKANG THERAPEUTICSM INC·Filed 2019·Application pending·0 cites
- 4946US2010204159A1Organic compounds and their usesBRANDL TRIXL·Filed 2007·Application pending·0 cites
- 5045US2020407365A1Indole-2-carbonyl compounds and their use for the treatment of hepatitis bNOVARTIS AG·Filed 2019·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jiping Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →